Academic Journal
Q1Applied Health Economics and Health Policy
About Applied Health Economics and Health Policy
About Applied Health Economics and Health Policy
Applied Health Economics and Health Policy is a peer-reviewed scholarly journal published by Springer Nature (Switzerland). It focuses on Q1. Publication coverage spans 2002-2006, 2008-2026.
Key indicators: ISSN 1175-5652, 1179-1896; H-index 60; Impact Factor 3.1.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (60): Strong citation impact — 60 articles cited at least 60 times each, reflecting solid influence.
- Impact Factor (3.1): Average citations per recent article. A solid figure indicating regular citation by the research community.
Publishing in Applied Health Economics and Health Policy
An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.
- Scope fit: Confirm your research aligns with Q1. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
- Submission: Submit via the official journal website.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of Applied Health Economics and Health Policy?
1175-5652, 1179-1896.
Who publishes Applied Health Economics and Health Policy?
Springer Nature.
What are Applied Health Economics and Health Policy's metrics?
Impact Factor 3.1; H-index 60.
Where do I submit to Applied Health Economics and Health Policy?
Via the official website.
Is Applied Health Economics and Health Policy peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Verified field sources
- Journal Impact Factor: 3.1 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
- Impact Factor year: 2025 — Official source; checked 2026-10-03. Journal metric year and editorial leadership as listed on the Springer Nature journal homepage.
Source-backed journal facts
Topics in published research
Health Systems, Economic Evaluations, Quality of Life; Pharmaceutical Economics and Policy; Healthcare Policy and Management; Global Health Care Issues; Economic and Environmental Valuation; Healthcare Systems and Reforms.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
4,990.00 USD; 3,890.00 EUR; 3,090.00 GBP
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Cost-Effectiveness of Annual Atrial Fibrillation Screening Compared with Current Opportunistic Screening in Australian Primary Care: A Model-Based Economic Evaluation
Ureni Halahakone, Sameera Senanayake, Victoria McCreanor, William Parsonage et al.
2026-10-09 · DOI: 10.1007/s40258-026-01073-zSpeed over Value: Korea’s Recent Overhaul in Pharmaceutical Pricing and Reimbursement
Hye-Young Kwon
2026-10-03 · DOI: 10.1007/s40258-026-01078-8An Early Value Assessment of Biomarker-Guided Precision Medicine for Treatment-Resistant Hypertension: A Headroom and Threshold Analysis
Teebah Abu-Zahra, Sabine Grimm, Mirre Scholte, Ana I. Casas et al.
2026-09-30 · DOI: 10.1007/s40258-026-01075-xA Practical Framework for Understanding Cost-Effectiveness and Decision Risk in Health Benefits Package Design
Cassandra Nemzoff, Sabine Grimm, Manuela Joore, Andres Madriz-Montero et al.
2026-09-30 · DOI: 10.1007/s40258-026-01072-0Spillover Effects of Medical Innovations: A Universal and Scalable Approach to Measure the Societal Value of Avoided Informal Care Time
Rebecca Grün, Diego Hernandez, Adnan Atitallah, Platon Peristeris et al.
2026-09-18 · DOI: 10.1007/s40258-026-01068-wEstimating the Share of Social Surplus Generated by Pharmaceutical Innovation Accruing to Manufacturers: A Systematic Literature Review
Robert J. Nordyke, Tyler D. Wagner, Janine Ross, Sreeranjani Menon et al.
2026-09-15 · DOI: 10.1007/s40258-026-01064-0Evaluating Mongolia’s Sugar-Sweetened Beverage Tax: A Cost-Effectiveness Analysis
Nyamdavaa Byambadorj, Rohan Best, Undram Mandakh, Kompal Sinha et al.
2026-09-10 · DOI: 10.1007/s40258-026-01070-2When Does Health Technology Assessment Need Deliberation? Evidence, Algorithms and the Limits of Consultation
Ahmet Küçükuncular, Anthony J. Culyer
2026-09-10 · DOI: 10.1007/s40258-026-01071-1A Scoping Review of the Literature on Child and/or Adolescent Health Microsimulation Models
Claire de Oliveira, Yingkun Justin Wen, Michael Endale Mengesha, Filipa Sampaio et al.
2026-09-09 · DOI: 10.1007/s40258-026-01066-yCost-Minimisation and Cost-Benefit Analysis of Reusable Menstrual Pads Compared to Disposable Pads in a Low-Resource Nigerian Setting
Amina Suleiman Rajah, Umar Lawal Bello, Ahmed Suberu, Muhammad Kamaluddeen Sani et al.
2026-09-09 · DOI: 10.1007/s40258-026-01069-9Pricing Combination Therapies: A Systematic Review of Value Attribution, Cost-Sharing Mechanisms and Policy Frameworks
Marta Trapero-Bertran, Carlos Martin-Saborido, Jorge Mestre-Ferrandiz, Nuria Amarilla et al.
2026-09-06 · DOI: 10.1007/s40258-026-01065-zJob Stress, Burnout and Healthcare Utilization: Evidence from a Systematic Literature Review and Implications for Future Research
Sabela Siaba, Berta Rivera, Luis Currais
2026-08-31 · DOI: 10.1007/s40258-026-01067-xCost-Effectiveness of Maternal RSVpreF Vaccination Compared with Newborn Nirsevimab RSV Prophylaxis or No RSV Prophylaxis in Switzerland
Jamie Bainbridge, Stuart Mealing, Charlotte Graham, Mathias Jenal et al.
2026-08-12 · DOI: 10.1007/s40258-026-01063-1Cost Effectiveness of Interventions for Perinatal Anxiety and/or Depression: A Systematic Review of Global Evidence
Ashwini Shivakumar Bidnurmath, Suganya Kumar, Filipa Sampaio
2026-07-29 · DOI: 10.1007/s40258-026-01059-xCost-Effectiveness of Adult Hepatitis A Vaccination Strategies in Korea Under an Aging Susceptibility Profile
Yuna Lim, Gerardo Chowell, Eunok Jung
2026-09 · DOI: 10.1007/s40258-026-01056-0COVID-19–Related Healthcare Utilization and Costs in a Large Insured US Population, 2021–2025
Xiaoyu Dong, Andrew J. Leidner, Jamison Pike, Bo-Hyun Cho et al.
2026-09 · DOI: 10.1007/s40258-026-01062-2Collaborating for Affordable Patient Access to Medicines: Review of the First Decade of the Beneluxa Initiative in Pharmaceutical Policy
Sabine Vogler, Verena Knoll, Anja Sonemann, Annemie Quanten et al.
2026-07-25 · DOI: 10.1007/s40258-026-01057-zActive Transport Health Model: Valuing the Health Benefits of Active Transport
Mary Njeri Wanjau, Holger Möller, Christopher Standen, Fiona Haigh et al.
2026-09 · DOI: 10.1007/s40258-026-01050-6Using Patient and Public Involvement to Develop a Survey for Economic Evaluation in Dementia Research
Gillian Eaglestone, Charlotte Stoner, Rosana Pacella, Paul McCrone et al.
2026-07-20 · DOI: 10.1007/s40258-026-01061-3A Review of the Application of Generic Preference-Based Instruments with Older People Across Care Settings
Kiri Lay, Jenny Cleland, Jyoti Khadka, Rachel Milte et al.
2026-09 · DOI: 10.1007/s40258-026-01060-4Reviews
Community Reviews
Version History
October 9, 2026 at 7:54 pm
September 25, 2026